COmparing CeNters ThRombectomy Aspiration STentretriever

NCT ID: NCT03412851

Last Updated: 2020-02-18

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

1000 participants

Study Classification

OBSERVATIONAL

Study Start Date

2018-04-01

Study Completion Date

2021-06-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Our aims is to evaluate the equality in efficacy and safety between direct aspiration technique and stent retriever thrombectomy procedure in anterior circulation strokes in a multicenter, prospective study.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Acute Stroke

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

A Direct Aspiration First Pass Technique

A Direct Aspiration First Pass Technique

Intervention Type OTHER

Distal aspiration technique

Stentriever Thrombectomy

Stentriever Thrombectomy

Intervention Type OTHER

Thrombectomy with stent retriever

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

A Direct Aspiration First Pass Technique

Distal aspiration technique

Intervention Type OTHER

Stentriever Thrombectomy

Thrombectomy with stent retriever

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Subject experiencing an acute ischemic stroke in which imaging demonstrates a vascular occlusion located in the distal internal carotid artery (ICA) through the distal middle cerebral artery (MCA).
* Subjects in which the aspiration technique is used for at least the first two thrombectomy passes per occluded vessel.
* Subjects older than 18 yo.
* Subjects with a prestroke modified Rankin scale of 0-2 and presenting with an NIHSS of 2-30.
* Subjects that the operator feels may be treated with endovascular therapy
* Subjects in which computed tomography (CT)/Magnetic Resonance Imaging (MRI) demonstrates an infarct size of less than 70cc on MRI or Alberta Stroke Program Early CT (ASPECTS) score overall of 6 or better.
* Subjects in which groin puncture can be obtained within 6 hours of symptom onset (with or without Total Plasminogen Activator administration). In those Patients of more than 8 hours or awake stroke or of unknown onset should be individualized the treatment and must exist area of penumbra in CT perfusion
* Subjects who have consented in accordance with local Institutional Review Board requirements

Exclusion Criteria

* Absence of large vessel occlusion on neuroimaging.
* Platelet count \< 100 x 10³ cells/mm³ or known platelet dysfunction.
* Contraindication to CT and/or MRI (i.e., due to contrast allergy or prior implant that precludes MRI imaging).
* Previously documented contrast allergy that is not amenable to medical treatment.
* Women who are pregnant or breastfeeding at time of intervention.
* Evidence of brain hemorrhage on CT and/or MRI at presenting hospital.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Hospitales Universitarios Virgen del Rocío

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Alejandro González

Principal Investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Alejandro González, MD, PhD

Role: PRINCIPAL_INVESTIGATOR

Hospitales Universitarios Virgen del Rocío

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Hospital Universitario de Cruces

Bilbao, , Spain

Site Status NOT_YET_RECRUITING

Hospital Universitario Reina Sofia

Córdoba, , Spain

Site Status NOT_YET_RECRUITING

Hospital Universitario Virgen de las Nieves

Granada, , Spain

Site Status NOT_YET_RECRUITING

Hospital Universitario Insular de Gran Canaria

Las Palmas de Gran Canaria, , Spain

Site Status NOT_YET_RECRUITING

Hospital Clínico Universitario Virgen de la Arrixaca

Murcia, , Spain

Site Status RECRUITING

Hospital Universitario Central de Asturias

Oviedo, , Spain

Site Status NOT_YET_RECRUITING

Hospital Universitario de Donostia

San Sebastián, , Spain

Site Status NOT_YET_RECRUITING

Hospital Universitario Marqués de Valdecilla

Santander, , Spain

Site Status NOT_YET_RECRUITING

Hospital Clínico Universitario

Valladolid, , Spain

Site Status NOT_YET_RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Spain

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Alejandro González, MD, PhD

Role: CONTACT

+34 696646686

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Alain Luna

Role: primary

Fernando Delgado, MD, PhD

Role: primary

Pedro Pablo Alcazar, MD, PhD

Role: primary

Yeray Aguilar, MD

Role: primary

Joaquin Zamarro, MD

Role: primary

Pedro Vega, MD

Role: primary

Pedro Navia, MD

Role: primary

Andrés González Mandly, MD

Role: primary

Juan Arenillas, MD, PhD

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

CO-18-V1.0

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.